BGT-002

N/A

Report date: 2023/02/27 20:00:18
NME

Base Information

Drug NameBGT-002
Drug Alias NameBGT-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP-citrate synthase inhibitors
TargetsATP-citrate synthase
Therapy Area/IndicationsHypercholesterolemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShanghai Institute Of Materia Medica, Chinese Academy Of Sciences
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesBojiyuan (Shanghai) Biopharmaceutical Co LtdBurgeon Therapeutics Co Ltd
Inactive CompaniesN/A
Active IndicationsHypercholesterolemiaMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A